Literature DB >> 5930704

[On thrombolytic therapy of a recent myocardial infarct. I. Introduction, treatment plans, general clinical results].

R Schmutzler, F Heckner, P Körtge, J van de Loo, H Poliwoda, F A Pezold, F Praetorius, D Zekorn.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 5930704     DOI: 10.1055/s-0028-1110619

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


× No keyword cloud information.
  7 in total

1.  Streptokinase thrombolysis in acute myocardial infarction: a turning point.

Authors:  P Angelini; R Leachman
Journal:  Tex Heart Inst J       Date:  1983-12

2.  Treatment of acute myocardial infarction with anisoylated plasminogen streptokinase activator complex.

Authors:  S Ikram; S Lewis; C Bucknall; I Sram; N Thomas; R Vincent; D Chamberlain
Journal:  Br Med J (Clin Res Ed)       Date:  1986-09-27

3.  Emerging Therapies: Pleiotropic Multi-target Drugs to Treat Stroke Victims.

Authors:  Paul A Lapchak
Journal:  Transl Stroke Res       Date:  2011-06-01       Impact factor: 6.829

4.  [Influence of anticoagulants and streptokinase on the course of acute myocardial infarct].

Authors:  V Hiemeyer; H Rasche; K Diehl
Journal:  Klin Wochenschr       Date:  1969-04-01

5.  [Coagulation studies and rheological measurements during streptokinase therapy of myocardial infarction (author's transl)].

Authors:  W Theiss; E Volger; A Wirtzfeld; I Keisel; H Blömer
Journal:  Klin Wochenschr       Date:  1980-06-16

6.  Streptokinase in acute myocardial infarction: a controlled multicentre study in the United Kingdom.

Authors:  C P Aber; N M Bass; C L Berry; P H Carson; R J Dobbs; K M Fox; J J Hamblin; S P Haydu; G Howitt; J E MacIver; R W Portal; E B Raftery; R H Rousell; J P Stock
Journal:  Br Med J       Date:  1976-11-06

7.  Streptokinase in recent myocardial infarction: a controlled multicentre trial. European working party.

Authors: 
Journal:  Br Med J       Date:  1971-08-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.